«Clinical and laboratory predictors of therapeutic response to Tocilizumab in rheumatoid arthritis». One Health & Risk Management 6, no. 3 (september 6, 2025): 44–53. åpnet juli 11, 2026. https://ojs.maxaccs.ie/index.php/journal-ohrm-bba-md/article/view/827.